Cargando…

Reassessing the death risk related to probiotics in critically ill patients

Detalles Bibliográficos
Autor principal:	Maraolo, Alberto Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126807/ https://www.ncbi.nlm.nih.gov/pubmed/27894315 http://dx.doi.org/10.1186/s13054-016-1565-1

Ejemplares similares

Response to “Reassessing the death risk related to probiotics in critically ill patients”
por: Manzanares, William, et al.
Publicado: (2017)

Probiotics in Critically Ill Patients
por: Moradi Moghaddam, Omid
Publicado: (2011)

Probiotics in critical illness
por: Klarin, B, et al.
Publicado: (1999)

Liver Illness and Psoriatic Patients
por: Fiore, Marco, et al.
Publicado: (2018)

Reassessing access to intensive care using an estimate of the population incidence of critical illness
por: Garland, Allan, et al.
Publicado: (2018)

Causes and timing of death in critically ill COVID-19 patients
por: Contou, Damien, et al.
Publicado: (2021)

Probiotics in critically ill children
por: Singhi, Sunit C., et al.
Publicado: (2016)

Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives
por: Fiore, Marco, et al.
Publicado: (2017)

Probiotics in Critically Ill Patients: An Umbrella Review
por: Naseri, Amirreza, et al.
Publicado: (2022)

Food-related illness and death in the United States.
por: Hedberg, C
Publicado: (1999)

Efficacy of probiotics in the prevention of diarrhea in ventilated critically ill ICU patients: meta-analysis of randomized control trials
por: Shimizu, Kentaro, et al.
Publicado: (2021)

Treating critically ill patients with probiotics: Beneficial or dangerous?
por: Jacobi, Christoph A, et al.
Publicado: (2011)

Exposure to peroxisome proliferators: reassessment of the potential carcinogenic hazard.
por: Roberts, R, et al.
Publicado: (2001)

A Critical Reassessment of the Role of Mitochondria in Tumorigenesis
por: Salas, Antonio, et al.
Publicado: (2005)

Reassessing HOLC redlining maps to support claims of environmental injustice
por: Gomby, Gary A.
Publicado: (2022)

Efficacy of probiotics in the prevention of diarrhea in ventilated critically ill ICU patients: meta-analysis of randomized control trials: author’s reply
por: Batra, Priyam, et al.
Publicado: (2021)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Bedside handover of critically ill patients
por: Wise, Matt P, et al.
Publicado: (2012)

Risk factors for death in chronic critical illness
por: Lokhandwala, S, et al.
Publicado: (2015)

Psychological support to relatives of critically ill patients with COVID-19
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2020)

Central Venous Catheter-Related Infection in Critically Ill Patients
por: dos Santos, Vitorino M., et al.
Publicado: (2019)

Insulin and the critically ill
por: Das, Undurti N
Publicado: (2002)

The nature of unmeasured anions in critically ill patients
por: Moviat, Miriam AM, et al.
Publicado: (2008)

Gastrointestinal failure score in critically ill patients
por: Berger, Mette M, et al.
Publicado: (2008)

Latent viral infections in critically ill patients
por: Wise, Matt P, et al.
Publicado: (2009)

Minimising drug errors in critically ill patients
por: Carson-Stevens, Andrew, et al.
Publicado: (2011)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Use of hydroxyethyl starch in critically ill patients
por: Bugedo, Guillermo, et al.
Publicado: (2013)

Enteral glutamine supplementation in critically ill patients
por: Tian, Xu, et al.
Publicado: (2015)

Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness
por: Wischmeyer, Paul E., et al.
Publicado: (2016)

Severe mental illness: reassessing COVID-19 vaccine priorities
por: Siva, Nayanah
Publicado: (2021)

Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients
por: Shimizu, Kentaro, et al.
Publicado: (2021)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

Tissue Doppler in critical illness
por: Chew, Michelle, et al.
Publicado: (2007)

Risk factors for early invasive fungal disease in critically ill patients
por: Sai Saran, P. V., et al.
Publicado: (2016)

Psychological symptoms in relatives of critically ill patients (ICU families): a prospective multicenter study
por: Hoffmann, M., et al.
Publicado: (2020)

Editorial for the Special Issue: “Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms”
por: Maraolo, Alberto Enrico
Publicado: (2022)

In critically ill patients the procalcitonin level can be misleading
por: Koeze, Jacqueline, et al.
Publicado: (2011)

What is the optimal fluid status in critically ill patients?
por: Chou, Yu-Hsiang
Publicado: (2012)

Iron Deficiency Defined by Hepcidin in Critically Ill Patients
por: Eisenga, Michele F.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h67p4abg2ph9cs47em81q557hs